Skip to main content
. 2011 Oct 5;2011(10):CD006423. doi: 10.1002/14651858.CD006423.pub2

Comparison 5.

Liraglutide 0.6 mg daily versus placebo

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 HbA1c (%) 1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
2 HbA1c < 7% 1 Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
3 Hypoglycaemia rate (events/patient‐year) Other data No numeric data
4 Severe hypoglycaemia Other data No numeric data
5 Weight change (kg) Other data No numeric data
6 Adverse events Other data No numeric data
7 Blood pressure (mm Hg) Other data No numeric data
8 Fasting plasma glucose (mmol/L) Other data No numeric data
9 Post‐prandial glucose / glucose profiles Other data No numeric data